Positioning no disclosures inside 60 days, left as found
Options put/call open interest 2.60, read 2026-11-04
Ethical does not pass the values gate
Price28.49 USD
Ethical score70.0/100
Our investment reviews on this name
2026-11-06Read Distribution28.49+0.0% to today Markdown gives way to Distribution
2026-11-05Read Markdown28.49+0.0% to today Accumulation gives way to Markdown after a 14% slide in 11 days
2026-10-25Read Accumulation33.27-14.4% to today Markdown gives way to Accumulation
2026-10-02Read Markdown33.26-14.3% to today ✓Accumulation gives way to Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Permian Basin Royalty Trust holds its Distribution at $28.49. Consolidating, no directional conviction, held for 1 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 1 days
Price at the screen
$28.49
Valuation
81.40 trailing · N/A forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.40
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
91.34%
Below 49%
Money owed to the company is 91.3% of assets, above the 49% limit.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Permian Basin Royalty Trust's business is fine, but its receivables are about 91% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PBT's ethical verdict changes
Today PBT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PBT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-05Markdown · changed$28.49-9.9%Entry 10
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$31.62-5.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 36% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
2026-10-18Markdown$34.60+4.0%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 52% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
2026-10-02Markdown · changed$33.26-1.2%Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 52% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 18.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 52% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
2026-08-08Markup$28.40-0.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 52% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
2026-07-18Markup$28.45+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 52% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 156%. Our forward projection puts the odds of a 10% gain over the next month near 37%.
2026-07-03Markup$28.45+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
